ImmunityBio Inc. has established a wholly owned subsidiary in Saudi Arabia to support regulatory submissions, commercial launches, and clinical development across the Middle East and North Africa. The company plans to open a regional office in the Kingdom to further support physicians and health systems in the region.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260217250658) on February 17, 2026, and is solely responsible for the information contained therein.